Pamela Stephenson - Dec 27, 2021 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Commercial Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Dec 27, 2021
Transactions value $
-$11,339
Form type
4
Date filed
12/27/2021, 03:02 PM
Previous filing
Sep 28, 2021
Next filing
Jan 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$11.3K -474 -1.82% $23.92 25.6K Dec 27, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 12,276 shares of common stock and 13,313 restricted stock units.